Understanding meningioma: Insights and options

Written in association with: Mr Pedro Oliveira Castanho
Published:
Edited by: Kate Forristal

In his latest online article, Mr Pedro Oliveira Castanho gives us his insights into meningioma. He talks about what meningioma is, the causes, how it's detected, if it should be removed, treatment options, the benefits and side effects and the outlook.  

 

What is meningioma, and what are the causes? 

Meningioma is a tumour originating from the membranes enveloping the brain and spinal cord. Generally, they are non-cancerous growths, although occasional cases may exhibit more aggressive behaviour. Rarely, malignant forms can occur, particularly in individuals with specific genetic predispositions.  

 

Determining a singular cause for meningiomas proves challenging, as they typically arise from a complex interplay of various factors rather than a singular origin. While hormonal influence, particularly in women, has been suggested, this connection remains incompletely understood. Recognised risk factors include exposure to radiation and the presence of certain genetic conditions like neurofibromatosis type 2, though these represent a minority of cases. 

 

How are meningioma typically detected? 

Brain scans may incidentally reveal meningiomas, even before they manifest any symptoms, often occurring during scans conducted for unrelated reasons such as falls or accidents. Patients with meningiomas may present with a range of symptoms, either individually or in combination. These symptoms encompass headaches, epileptic seizures, alterations in behaviour or memory, weakness and sensations in the arms or legs, facial drooping, and double or blurred vision, among others. The absence of specific symptoms for meningiomas highlights the variability, influenced by factors like location, size, and the extent of swelling within the brain

 

When should meningiomas be removed? 

If there are clear signs of significant symptoms, growth on consecutive scans, or indications of more aggressive behaviour, it may be necessary to consider surgical removal. 

 

What treatment options are available for meningiomas? 

Surgery to either remove or shrink the tumour is often advised for the mentioned tumours. Another option is the Gamma Knife, which might be the preferred treatment for certain patients, aiming to prevent tumour growth. In some cases, merely monitoring with regular imaging may be sufficient for managing meningiomas. Currently, there is no medication specifically designed to treat these tumours effectively. However, various medications can assist in symptom control, such as alleviating headaches, managing seizures, or reducing brain swelling. In certain situations, a combination of these treatments and other approaches may be necessary. 

 

Can you explain the benefits and potential side effects of each treatment? 

The term "Gamma Knife" might sound misleading because there's no cutting involved. It's a minimally invasive procedure where targeted gamma rays are used on the tumour, minimising impact on the surrounding brain. Despite the unusual idea of using radiation for tumours caused by it, the high dose is precisely aimed at the unhealthy tissue. Usually done in a day and as a single treatment, the procedure might take a few minutes to a few hours. Beforehand, you'll be admitted for necessary investigations.  

 

While generally well-tolerated, common symptoms on the day may include headaches, dizziness, and light-headedness, manageable with later medication. Temporary hair loss and transient brain swelling, also controllable with medication, are potential experiences for patients. Long-term side effects are rare, with exceedingly rare occurrences of radiation necrosis and radiation-induced tumours.  

 

On the other hand, surgery has the potential to cure but is the most invasive option, requiring general anaesthesia. Operations usually go as planned with common post-operative effects like wound pain and swelling. However, there is a small risk of serious complications or death, and the severity of risks varies depending on the tumour’s complexity

 

What is the outlook for meningiomas? 

Meningiomas are complex tumours that usually need long-term monitoring, no matter how they're treated. The good news is, with the right care, they're often curable or manageable. In these cases, people should be able to lead a regular life and have a normal life expectancy

 

Mr Pedro Oliveira Castanho is an esteemed neurosurgeon with over 20 years of experience. You can schedule an appointment with Mr Castanho on his Top Doctors profile.  

By Mr Pedro Oliveira Castanho
Neurosurgery

Mr Pedro Oliveira Castanho is a highly regarded consultant neurosurgeon based in London with specialist expertise in the diagnosis, management and treatment of neurovascular conditions (neurovascular malformation)skull base conditions, and brain tumours. With over 20 years of experience, he is also highly proficient in degenerative spine and peripheral nerve entrapment syndromes and tumours, as well as in performing bypass surgery and pituitary surgery.

Mr Oliveira Castanho, who consults privately at the renowned Queen Square Radiosurgery Centre, earned his medical degree from the University of Coimbra in 2002. He undertook his higher specialist training at the distinguished Central Lisbon University and Hospital Centre and later went on to accomplish state-of-the-art training across the different domains of neurosurgery at the most reputed centres in the UK, USA, Germany, Finland, and Brazil.

As an expert in Leksell Gamma Knife radiosurgery, Mr Oliveira Castanho is also particularly trained in minimally invasive and endoscopic surgery to manage lesions in the brain, using advanced precision techniques to preserve healthy tissue. Worldwide, Mr Oliveira Castanho is one of the few pioneers in the use of exoscopic surgery, a new technique employed in lateral skull-base surgery that combines endoscopic and microscopic approaches.

Beyond his accomplished clinical practice, Mr Oliveira Castanho remains actively involved in advancing the field of neurosurgery. He regularly offers courses on the management of cervicobrachialgia, spondylotic myelopathy and posterior fossa tumours, and as a prominent figure in his specialty, he has also acted as a co-ordinator for a number of high-impact peer-reviewed publications. Furthermore, Mr Oliveira Castanho holds an honorary senior clinical lecturer position at University College London, where he provides both undergraduate and postgraduate teaching.

View Profile

Overall assessment of their patients


  • Related procedures
  • Chronic headache
    Neuropathic pain
    Epilepsy
    Alzheimer's disease
    Movement disorders
    Transient ischaemic attack (TIA)
    Trapped nerve
    Scoliosis
    Spine fracture
    Rhizotomy
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.